MAXONA has assembled a highly experienced and well recognized management team with a proven record of successfully developing and commercializing effective therapeutics.
Roy Freeman M.D. 
Senior Medical Advisor
- Professor of Neurology at Harvard Medical School
- Authority on neuropathic pain, neuropathic pain clinical trial design, & peripheral nervous system disorders
Shawn Fatholahi
President & CEO
- Commercial executive with record of success across a range of therapeutic areas including Neuroscience
- Built and grew IMPAX Laboratories brand commercial business from one employee to 130 and $245 million in revenues
Arthur Koch, Jr.
Chief Financial Officer
- Prior CFO at IMPAX Laboratories, Strategic Diagnostics and IBAH
- Experienced in all facets of financial operations of public and private companies including start-ups
Edward Allera J.D.
GC & Chief Legal Advisor
- Partner at Buchanan, Ingersoll, & Rooney PC
- Prior FDA Counsel – Recognized FDA regulatory expert
Bob Rappaport M.D.
Chief Regulatory Advisor
- Prior FDA Division Director – Anesthesia, Analgesia, and Addiction Drug Products
- Independent consultant on regulatory matters